r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
A side-by-side editorial comparison of cloudml and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.
Six years since the last functional change, and Google renamed the service it wraps in the release before that
cloudml lets R users train keras, tfestimators and tensorflow models on Google's managed machine learning service, tune hyperparameters there, and deploy the results. Its last release with functional content was 0.6.1 in September 2019, which adapted to Google renaming the service from ml-engine to ai-platform. The only entry since is a 2025 documentation update made to satisfy CRAN.
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
cloudml lets R users train keras, tfestimators and tensorflow models on Google's managed machine learning service, tune hyperparameters there, and deploy the results. Its last release with functional content was 0.6.1 in September 2019, which adapted to Google renaming the service from ml-engine to ai-platform. The only entry since is a 2025 documentation update made to satisfy CRAN.
The visible arc is short and stops abruptly. Releases through 2018 tracked the TensorFlow runtime version and patched packaging problems; 0.6.1 added a customCommands hook so users could run OS-level setup before package installation, and adjusted to the service's new name. Then nothing for six years. A 2025 release containing only documentation changes is the standard signal of a package being kept on CRAN rather than being developed.
There is nothing in this feed to support a prediction of functional work. The most likely next event is another CRAN-driven documentation patch, or archival.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either cloudml or pharmaverseadam.
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul took mocking back from webmockr and made it a property of the client itself
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
See all cloudml alternatives → · See all pharmaverseadam alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. cloudml and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. cloudml and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top cloudml alternatives in Analytics are ranked by recent ship velocity. Browse the "cloudml alternatives" section above for the current picks, or visit /alternatives/cloudml for the full list with editorial commentary on each.
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.